| Online-Ressource |
Verfasst von: | Konnopka, Alexander [VerfasserIn]  |
| Kaufmann, Claudia [VerfasserIn]  |
| Wild, Beate [VerfasserIn]  |
| Szecsenyi, Joachim [VerfasserIn]  |
| Herzog, Wolfgang [VerfasserIn]  |
| Schellberg, Dieter [VerfasserIn]  |
| Schäfert, Rainer [VerfasserIn]  |
Titel: | Cost-utility of a specific collaborative group intervention for patients with functional somatic syndromes |
Verf.angabe: | Alexander Konnopka Dr., Hans-Helmut König Prof., Claudia Kaufmann Dr., Nina Egger Dr., Beate Wild Prof., Joachim Szecsenyi Prof., Wolfgang Herzog Prof., Dieter Schellberg Dipl.-Psych., Rainer Schaefert PD |
E-Jahr: | 2016 |
Jahr: | 1 September 2016 |
Umfang: | 8 S. |
Teil: | volume:90 |
| year:2016 |
| supplement:Supplement C |
| pages:43-50 |
| extent:8 |
Fussnoten: | Gesehen am 27.11.2017 |
Titel Quelle: | Enthalten in: Journal of psychosomatic research |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1956 |
Jahr Quelle: | 2016 |
Band/Heft Quelle: | 90(2016), Supplement C, Seite 43-50 |
ISSN Quelle: | 1879-1360 |
Abstract: | Collaborative group intervention (CGI) in patients with functional somatic syndromes (FSS) has been shown to improve mental quality of life. To analyse incremental cost-utility of CGI compared to enhanced medical care in patients with FSS. An economic evaluation alongside a cluster-randomised controlled trial was performed. 35 general practitioners (GPs) recruited 300 FSS patients. Patients in the CGI arm were offered 10 group sessions within 3months and 2 booster sessions 6 and 12months after baseline. Costs were assessed via questionnaire. Quality adjusted life years (QALYs) were calculated using the SF-6D index, derived from the 36-item short-form health survey (SF-36). We calculated patients' net-monetary-benefit (NMB), estimated the treatment effect via regression, and generated cost-effectiveness acceptability curves. Using intention-to-treat analysis, total costs during the 12-month study period were 5777EUR in the intervention, and 6858EUR in the control group. Controlling for possible confounders, we found a small, but significant positive intervention effect on QALYs (+0.017; p=0.019) and an insignificant cost saving resulting from a cost-increase in the control group (−10.5%; p=0.278). NMB regression showed that the probability of CGI to be cost-effective was 69% for a willingness to pay (WTP) of 0EUR/QALY, increased to 92% for a WTP of 50,000EUR/QALY and reached the level of 95% at a WTP of 70,375EUR/QALY. Subgroup analyses yielded that CGI was only cost-effective in severe somatic symptom severity (PHQ-15≥15). CGI has a high probability to be a cost-effective treatment for FSS, in particular for patients with severe somatic symptom severity. |
DOI: | doi:10.1016/j.jpsychores.2016.09.001 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: http://dx.doi.org/10.1016/j.jpsychores.2016.09.001 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S0022399916303828 |
| DOI: https://doi.org/10.1016/j.jpsychores.2016.09.001 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Collaborative care |
| Cost-effectiveness |
| Functional somatic syndromes |
K10plus-PPN: | 1565724534 |
Verknüpfungen: | → Zeitschrift |
Cost-utility of a specific collaborative group intervention for patients with functional somatic syndromes / Konnopka, Alexander [VerfasserIn]; 1 September 2016 (Online-Ressource)